StopDown
Funding · 25 March 2026ELMED Life Sciences$2.7 million (₹25 crore)Probiotic and biological solutions provider

ELMED Life Sciences raises $2.7 million Series A

By · Editor ·

Series AHyderabadFounded 2018
  • ELMED makes probiotic-based solutions for animal health, agriculture, aquaculture and human health
  • It raised $2.7 million in Series A funding from AgriSURE Fund, managed by NABVENTURES
  • The company is the first in India to develop probiotics specifically for agriculture

What happened

  • ELMED Life Sciences raised $2.7 million (₹25 crore) in Series A funding.
  • The round was led by AgriSURE Fund, managed by NABVENTURES, the venture capital arm of NABARD.
  • The company will use the funds to expand manufacturing in Hyderabad.
  • It will also strengthen R&D in microbiome-based solutions.
  • ELMED plans to scale distribution across Tier 2 and Tier 3 Indian markets.
  • It aims to build presence in international markets like Europe, Asia and LATAM.
  • The company focuses on a ONE HEALTH approach, linking human, animal and environmental health.

Why it matters

  • Global and Indian agriculture is shifting to biological and microbiome-based solutions due to antibiotic restrictions and export standards.
  • The Indian probiotic segment in animal health, aquaculture and agriculture is growing rapidly.
  • Investor interest in microbiome solutions is picking up, with examples like The Good Bug raising ₹100 crore and GreenGrahi raising ₹32 crore.

The business

  • ELMED is a science-led company offering probiotic and biological solutions across animal health, aquaculture, agriculture and human health.
  • Its products include probiotic-based solutions for poultry, dairy, livestock, shrimp, fish farming and soil/plant health.
  • It offers contract manufacturing and R&D services to global healthcare and agri-biotech companies.
  • Top clients include Xanum, Hetero Healthcare, Wallace Pharmaceuticals and Donovan.
  • Its facility in Hyderabad produces probiotics in oral suspensions, emulsions, drops, capsules, sachets and syrups for humans, aquatic life, animals and plants.
  • ELMED is the first company in India to research and develop probiotics specifically for agriculture.
  • It follows a B2B approach and serves multiple notable MNCs.
  • The company exports to more than 18 countries.

The founders

Pruthivin Reddy Madduri

Founder & Managing Director
  • He is a VIT alumnus.
  • He founded ELMED Life Sciences in 2018.

Nikhil Konkathi

Co-founder
  • He is a VIT alumnus.
  • He co-founded ELMED Life Sciences in 2018.

Who put in money

  • AgriSURE Fund lead — AgriSURE Fund is managed by NABVENTURES, the venture capital arm of NABARD.

In numbers

$2.7 million (₹25 crore)Funding amount · 2026
₹17.0 croreRevenue · FY25
₹11.4 croreRevenue · FY24
48.3%Revenue growth · FY25 vs FY24
59Employees · 2026
18+Export countries · 2026
530Web traffic (30 days) · 2026

What happens next

  • Expand manufacturing capacity in Hyderabad.
  • Strengthen R&D in microbiome-based solutions.
  • Scale distribution across Tier 2 and Tier 3 Indian markets.
  • Build presence in international markets including Europe, Asia and LATAM.
  • Focus on the ONE HEALTH approach.

Words to know

Series A
The first significant round of venture capital funding, typically used to scale operations and product development.
Probiotics
Live beneficial bacteria that improve health of humans, animals or plants.
Microbiome
The community of microorganisms living in a particular environment, such as the gut or soil.
ONE HEALTH
An approach that recognizes the interconnection between human health, animal health and the environment.

The numbers around it

Agriculture & Food Systems in March 2026: 9 rounds with a disclosed amount, $97.2 million in all; the biggest was Captain Fresh (Rs 290 crore). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.

Everything on ELMED Life Sciences → · All startup news on 25 March 2026 →

Is this ELMED Life Sciences? Get your “Featured on StopDown” badge →